Advertisement
Advertisement
NVST
Envista Holdings Corporation Common stock, $0.01 par value per share
23.27
USDSponsored
-0.48
-2.02%
Nov 19, 15:59 UTC -5
Closed
After-Market
23.27
0.00
+0.02%
Envista Holdings Corporation Common stock, $0.01 par value per share (NVST) Earnings
NVST Earnings Reports
Positive Surprise Ratio
NVST beat 22 of 29 last estimates.
76%
Next Report
Date of Next Report
Feb 03, 2027
Estimate for Q4 26 (Revenue/ EPS)
$761.49M
/$0.40
Implied change from Q3 26 (Revenue/ EPS)
+10.12%
/--
Implied change from Q4 25 (Revenue/ EPS)
+1.45%
/+5.26%
Envista Holdings Corporation Common stock, $0.01 par value per share earnings per share and revenue
On Nov 04, 2026, NVST reported earnings of 0.40 USD per share (EPS) for Q3 26, beating the estimate of 0.36 USD, resulting in a 10.13% surprise. Revenue reached 691.50 million, compared to an expected 702.51 million, with a -1.57% difference. The market reacted with a -8.20% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.40 USD, with revenue projected to reach 761.49 million USD, implying an increase of 0.00% EPS, and increase of 10.12% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%

Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%

Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%

MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%

Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%

Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-Actual
$0.10
Surprise
-

FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%

Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%

Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%

Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
What were Envista Holdings Corporation Common stock, $0.01 par value per share's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Envista Holdings Corporation Common stock, $0.01 par value per share reported EPS of $0.40, beating estimates by 10.13%, and revenue of $691.50M, -1.57% below expectations.
How did the market react to Envista Holdings Corporation Common stock, $0.01 par value per share's Q3 2026 earnings?
The stock price moved down -8.2%, changed from $27.19 before the earnings release to $24.96 the day after.
When is Envista Holdings Corporation Common stock, $0.01 par value per share expected to report next?
The next earning report is scheduled for Feb 03, 2027.
What are the forecasts for Envista Holdings Corporation Common stock, $0.01 par value per share's next earnings report?
Based on --
analysts, Envista Holdings Corporation Common stock, $0.01 par value per share is expected to report EPS of $0.40 and revenue of $761.49M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.